Third Wave Shares Drop 5.5 Percent After Analyst Downgrades Stock on Poor Q4 Earnings | GenomeWeb

This is a corrected version of a previous article reporting that two analysts downgraded Third Wave's stock. In fact, one analyst, for Cairns & Company, downgraded the stock.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.